| Jessica Kruszka, RN | |
|
495 Jack Martin Blvd Ste 6, Brick, NJ 08724-7778 | |
| (732) 344-0596 | |
| Not Available |
| Full Name | Jessica Kruszka |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Addiction (substance Use Disorder) |
| Location | 495 Jack Martin Blvd Ste 6, Brick, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508532078 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WA0400X | Registered Nurse - Addiction (substance Use Disorder) | 26NR21657900 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Kruszka, RN 8 Palermo Dr, Tinton Falls, NJ 07724-3824 Ph: (917) 868-5197 | Jessica Kruszka, RN 495 Jack Martin Blvd Ste 6, Brick, NJ 08724-7778 Ph: (732) 344-0596 |
News Archive
In light of an aging population and increasing chronic vascular disease, there is a tremendous unmet need for new medical technologies to treat potentially dangerous chronic venous insufficiency (CVI) and blood clots, according to a Scientia Advisors review of the vascular device market released today. Both the CVI and the thrombosis segments present significant opportunities for medical device innovators.
A consortium of researchers headed by Cincinnati Children's Hospital Medical Center has discovered a gene expression pattern that could lead to improved diagnosis and treatment of pediatric septic shock , still a serious public health problem despite today's potent antibiotics and pediatric intensive care units.
Human white blood cells, engineered to recognize other malignant immune cells, could provide a novel therapy for patients with highly lethal B cell cancers such as acute lymphoblastic leukemia (ALL), according to researchers at Memorial Sloan-Kettering Cancer Center (MSKCC).
Health experts come together today (Thursday) to warn that a new form of superbug that gives bacteria the power to resist virtually all known antibiotics is spreading quickly, posing a global health disaster. It is called New Delhi metallobeta-lactamase, or NDM-1 for short. This enzyme destroys carbapenems, an important group of antibiotics used for difficult infections in hospitals, and has been found in a wide variety of bacterial types. British researchers last August reported that infections involving NDM-1 had been found in patients in Bangladesh, India, Pakistan and Britain.
Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).
› Verified 6 days ago
Alison Griffin, Registered Nurse Medicare: May Accept Medicare Assignments Practice Location: 1500 Route 88, Brick, NJ 08724 Phone: 732-785-1900 | |
Mrs. Patricia Mccue Witkowski, A.P.N. Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 989 Burnt Tavern Rd Ste 2, Brick, NJ 08724 Phone: 732-836-3049 | |
Ms. Kimberly Reilly, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 495 Jack Martin Blvd Ste 6, Brick, NJ 08724 Phone: 732-344-0596 | |
Yan Pan, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 12 N Pier, Brick, NJ 08723 Phone: 646-588-8911 | |
Donna Ebberup Ciervo, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 495 Jack Martin Blvd Ste 6, Brick, NJ 08724 Phone: 732-344-0596 | |
Caitlin Brianna Powers, Registered Nurse Medicare: Medicare Enrolled Practice Location: 525 Jack Martin Blvd Ste 301, Brick, NJ 08724 Phone: 732-840-0067 |